文献速递肝病消化道肿瘤与早癌

细胞外囊泡未注释小RNA簇可检测早期肝癌

Unannotated small RNA clusters associated with circulating extracellular vesicles detect early stage liver cancer.
PubMed 文献 · Gut · 2021-07-28

研究对血浆细胞外囊泡中的小RNA进行全基因组测序,鉴定出以20 nt共识序列为主的未注释小RNA簇,并构建3-smRC特征。该特征在157例HCC患者血浆中显著过表达(p<0.01),独立验证(n=209)检测早期HCC的敏感性86%、特异性91%、AUC 0.87,且独立于甲胎蛋白(p<0.0001),联合模型AUC升至0.93。

要点

  • 血浆EV小RNA以未注释、20 nt共识序列的小RNA簇为主。
  • 3-smRC特征检测早期HCC敏感性86%、特异性91%、AUC 0.87。
  • 3-smRC独立于甲胎蛋白,联合模型AUC提高至0.93。

核心结论

  • 未注释小RNA簇有望成为微创、仅需血液、不依赖操作者的HCC监测工具。

研究设计与样本

  • 采用差异超速离心分离EV,并结合nanoDLD阵列,通过电镜、免疫印迹、纳米颗粒追踪和去卷积分析评估质量。
  • 对未注释小RNA景观进行全基因组测序,鉴定并可重复定量小RNA簇(smRCs)。
  • 使用三个独立exRNA癌症数据集,共479份样本、375例患者,含纵向样本。

主要发现

  • exRNA smRCs以未表征、未注释的小RNA为主,共识序列为20 nt。
  • 未注释3-smRC特征在HCC患者血浆exRNA中显著过表达(p<0.01,n=157)。
  • 独立验证(n=209)显示检测早期HCC的敏感性86%、特异性91%,AUC为0.87。
  • 3-smRC特征独立于甲胎蛋白(p<0.0001),复合模型AUC提高至0.93。

关键数值与推荐

  • 3-smRC特征检测早期HCC:敏感性86%、特异性91%、AUC 0.87(n=209)。
  • 3-smRC特征与甲胎蛋白独立(p<0.0001),复合模型AUC 0.93。

临床怎么用

  • 提示可基于血浆EV小RNA开发微创、不依赖操作者的HCC监测工具。
  • 3-smRC特征可与甲胎蛋白联合构建复合模型以提高检测效能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Surveillance tools for early cancer detection are suboptimal, including hepatocellular carcinoma (HCC), and biomarkers are urgently needed. Extracellular vesicles (EVs) have gained increasing scientific interest due to their involvement in tumour initiation and metastasis; however, most extracellular RNA (exRNA) blood-based biomarker studies are limited to annotated genomic regions. DESIGN: EVs were isolated with differential ultracentrifugation and integrated nanoscale deterministic lateral displacement arrays (nanoDLD) and quality assessed by electron microscopy, immunoblotting, nanoparticle tracking and deconvolution analysis. Genome-wide sequencing of the largely unexplored small exRNA landscape, including unannotated transcripts, identified and reproducibly quantified small RNA clusters (smRCs). Their key genomic features were delineated across biospecimens and EV isolation techniques in prostate cancer and HCC. Three independent exRNA cancer datasets with a total of 479 samples from 375 patients, including longitudinal samples, were used for this study. RESULTS: ExRNA smRCs were dominated by uncharacterised, unannotated small RNA with a consensus sequence of 20 nt. An unannotated 3-smRC signature was significantly overexpressed in plasma exRNA of patients with HCC (p<0.01, n=157). An independent validation in a phase 2 biomarker case-control study revealed 86% sensitivity and 91% specificity for the detection of early HCC from controls at risk (n=209) (area under the receiver operating curve (AUC): 0.87). The 3-smRC signature was independent of alpha-fetoprotein (p<0.0001) and a composite model yielded an increased AUC of 0.93. CONCLUSION: These findings directly lead to the prospect of a minimally invasive, blood-only, operator-independent clinical tool for HCC surveillance, thus highlighting the potential of unannotated smRCs for biomarker research in cancer.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. von Felden J, Garcia-Lezana T, Dogra N, et al. Unannotated small RNA clusters associated with circulating extracellular vesicles detect early stage liver cancer. Gut. 2021. PMID: 34321221. doi:10.1136/gutjnl-2021-325036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。